Ë÷Òý³¬³öÁËÊý×é½çÏÞ¡£ ÎÄÕÂÕªÒª
|±¾ÆÚĿ¼/Table of Contents|

[1]ÕÅÎÄ³É Ò¦ÑÇÀö.ÐÄÔàÖ²Èëʽµç×Ó×°Öõ¼ÏßÏà¹ØÈý¼â°ê·´Á÷µÄÑо¿½øÕ¹[J].¹ú¼ÊÐÄѪ¹Ü²¡ÔÓÖ¾,2020,03:132-135+156.
µã»÷¸´ÖÆ

ÐÄÔàÖ²Èëʽµç×Ó×°Öõ¼ÏßÏà¹ØÈý¼â°ê·´Á÷µÄÑо¿½øÕ¹(PDF)

¡¶¹ú¼ÊÐÄѪ¹Ü²¡ÔÓÖ¾¡·[ISSN:1006-6977/CN:61-1281/TN]

ÆÚÊý:
2020Äê03ÆÚ
Ò³Âë:
132-135+156
À¸Ä¿:
×ÛÊö
³ö°æÈÕÆÚ:
2020-06-08

ÎÄÕÂÐÅÏ¢/Info

Title:
-
×÷Õß:
ÕÅÎÄ³É Ò¦ÑÇÀö
730000 À¼ÖÝ´óѧµÚÒ»¸½ÊôÒ½ÔºÐÄѪ¹ÜÄÚ¿Æ
Author(s):
-
¹Ø¼ü´Ê:
ÐÄÔàÖ²Èëʽµç×Ó×°Öà µç¼« Èý¼â°ê·´Á÷
Keywords:
-
·ÖÀàºÅ:
-
DOI:
10.3969/j.issn.1673-6583.2020.03.002
ÎÄÏ×±êʶÂë:
-
ÕªÒª:
´ó¶àÊýÐÄÔàÖ²Èëʽµç×Ó×°ÖÃ(CIED)¶¼ÐèÒª¿ç¹ýÈý¼â°êÖ²ÈëÓÒÊҵ缫µ¼Ïß¡£µ¼ÏßÏà¹ØÈý¼â°ê·´Á÷ÊÇÖ¸ÓÉÓÚÓÒÊÒµ¼ÏßÖ²ÈëÒýÆðз¢ÏÖ»ò½øÐÐÐÔ¼ÓÖصÄÈý¼â°ê·´Á÷¡£ÆäÓ°ÏìÒòËØÓÐÊõÇ°Èý¼â°ê·´Á÷³Ì¶È¡¢ÓÒÊÒÊæÕÅÄ©ÄÚ¾¶¡¢·Î¶¯Âö¸ßѹ¡¢ÐÄ·¿²ü¶¯¡¢µç¼«µ¼ÏßÖÖÀàºÍÊýÁ¿¡¢µç¼«µ¼Ïß¼â¶ËλÖõȡ£¸ÃÎĽéÉÜCIEDµ¼ÏßÏà¹ØÈý¼â°ê·´Á÷µÄÁ÷Ðв¡Ñ§Ìص㡢·¢Éú»úÖÆ¡¢Î£ÏÕÒòËØ¡¢ÁÙ´²±íÏÖ¼°ÖÎÁÆ¡£
Abstract:
-

²Î¿¼ÎÄÏ×/References

[ 1 ] Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival[J]. J Am Coll Cardiol, 2004, 43(3):405-409.
[ 2 ] Dokainish H, Elbarasi E, Masiero S, et al. Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: background, rationale, and design[J]. Glob Cardiol Sci Pract, 2015, 2015(3):41.
[ 3 ] Chang JD, Manning WJ, Ebrille E, et al. Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation[J]. J Am Coll Cardiol, 2017, 69(18):2331-2341.
[ 4 ] Paniagua D, Aldrich HR, Lieberman EH, et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads[J]. Am J Cardiol, 1998, 82(9):1130-1132.
[ 5 ] Klutstein M, Balkin J, Butnaru A, et al. Tricuspid incompetence following permanent pacemaker implantation[J]. Pacing Clin Electrophysiol, 2009,32(Suppl 1):S135-S137.
[ 6 ] Kucukarslan N, Kirilmaz A, Ulusoy E, et al. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads[J]. J Card Surg, 2006, 21(4):391-394.
[ 7 ] Arabi P, ?zer N, Ate ÿðþ‰D AH, et al. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions[J]. Cardiol J, 2015, 22(6):637-644.
[ 8 ] Al-Bawardy R, Krishnaswamy A, Rajeswaran J, et al. Tricuspid regurgitation and implantable devices[J]. Pacing Clin Electrophysiol, 2015, 38(2):259-266.
[ 9 ] Delling FN, Hassan ZK, Piatkowski G, et al. Tricuspid regurgitation and mortality in patients with transvenous permanent pacemaker leads[J]. Am J Cardiol, 2016, 117(6):988-992.
[10] Fanari Z, Hammami S, Hammami MB, et al. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation[J]. J Electrocardiol, 2015, 48(5):791-797.
[11] Lee RC, Friedman SE, Kono AT, et al. Tricuspid regurgitation following implantation of endocardial leads: incidence and predictors[J]. Pacing Clin Electrophysiol, 2015, 38(11):1267-1274.
[12] Alizadeh A, Sanati HR, Haji-Karimi M, et al. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing[J]. Europace, 2011, 13(11):1587-1590.
[13] Baquero GA, Yadav P, Skibba JB, et al. Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads[J]. J Interv Card Electrophysiol, 2013, 38(3):197-202.
[14] H?ke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up[J]. Heart, 2014, 100(12):960-968.
[15] Addertia K, Maffessanti F, Mediratta A, et al. Impact of implantable transvenous device lead location on severity of tricuspid regurgitation[J]. J Am Soc Echocardiogr, 2014, 27(11):1164-1175.
[16] Lin G, Nishimura RA, Connolly HM, et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads[J]. J Am Coll Cardiol, 2005, 45(10):1672-1675.
[17] Pfannmueller B, Hirnle G, Seeburger J, et al. Tricuspid valve repair in the presence of a permanent ventricular pacemaker Lead[J]. Eur J Cardiothorac Surg, 2011, 39(5):657-661.
[18] Epstein AE, Kay GN, Plumb VJ, et al. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads[J]. Circulation, 1998, 98(15):1517-1524.
[19] Mediratta A, Addetia K, Yamat M, et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation[J]. JACC Cardiovasc Imaging, 2014, 7(4):337-347.
[20] Mutlak D, Aronson D, Lessick J, et al. Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity?[J]. Chest, 2009, 135(1):115-121.
[21] Àî¹ú²Ý, ÀîÓ¨, ¸ßÁ¬¾ý, µÈ. ÐÄÔàÆð²«Æ÷Ö²ÈëÊõºóÈý¼â°ê·´Á÷Ó°ÏìÒòËØ·ÖÎö[J]. ÖлªÐÄÂÉʧ³£Ñ§ÔÓÖ¾, 2018, 22(3):222-228.
[22] Supple GE, Ren JF, Zado ES, et al. Mobile thrombus on device leads in patients undergoing ablation: identification, incidence, location, and association with increased pulmonary artery systolic pressure[J]. Circulation, 2011, 124(7):772-778.
[23] Najib MQ, Vinales KL, Vittala SS, et al. Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation[J]. Echocardiography, 2012, 29(2):140-146.
[24] Najib MQ, Vittala SS, Challa S, et al. Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads[J]. Tex Heart Inst J, 2013, 40(5):529-533.
[25] ÐìÉÐÓþ, ÌÆʤ»Ý, ÉòÐñ. ÓÀ¾ÃÐÔÐÄÔàË«Ç»Æð²«Æ÷ÓÒÐÄÊÒ²»Í¬Æð²«Î»µã¶ÔÈý¼â°ê·´Á÷µÄÓ°Ïì[J]. ÁëÄÏÐÄѪ¹Ü²¡ÔÓÖ¾, 2018, 24(5):544-547.
[26] Vaturi M, Kusniec J, Shapira Y, et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode[J]. Eur J Echocardiogr, 2010, 11(6):550-553.
[27] ÕÔ²¨, Ëν¨Æ½, ×Þ²Ù. ³¤ÆÚÓÒÊÒÐļⲿÆ𲫶ÔÈý¼â°ê·µÁ÷µÄÓ°Ïì[J]. ÖйúÐÄÔàÆð²«ÓëÐĵçÉúÀíÔÓÖ¾, 2012, 26(4):315-318.
[28] Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRA expert consensus statement on Lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS[J]. Europace, 2018, 20(7):1217.
[29] Coffey JO, Sager SJ, Gangireddy S, et al. The impact of transvenous lead extraction on tricuspid valve function[J]. Pacing Clin Electrophysiol, 2014, 37(1):19-24.
[30] Uehara K, Minakata K, Watanabe K, et al. Tricuspid valve repair for severe tricuspid regurgitation due to pacemaker leads[J]. Asian Cardiovasc Thorac Ann, 2016, 24(6):541-545.
[31] Hasumi E, Fujiu K, Kawata T, et al. The influence of His bundle pacing on tricuspid valve functioning using three-dimensional echocardiography[J]. HeartRhythm Case Rep, 2018, 4(9):437-438.

±¸×¢/Memo

±¸×¢/Memo:
»ù½ðÏîÄ¿:¸ÊËàÊ¡ÎÀÉúÐÐÒµ¿ÆÑмƻ®ÏîÄ¿(GSWSKY-2015-45)
×÷Õßµ¥Î»:730000 À¼ÖÝ´óѧµÚÒ»¸½ÊôÒ½ÔºÐÄѪ¹ÜÄÚ¿Æ
ͨÐÅ×÷Õß:Ò¦ÑÇÀö,E-mail:yaoyalifs@163.com
¸üÐÂÈÕÆÚ/Last Update: 2020-06-08